GlaxoSmithKline plc is a global healthcare company that develops, manufactures, and markets pharmaceuticals and consumer healthcare products. The document provides an overview of GSK, including its business operations, financial performance over time, analyst recommendations and valuations using different methods. The discounted dividend model valuation of £24.84 per share is considered the most appropriate given the growth rates used are lower than the cost of capital rate and closest to the current market price.